血管腔内主动脉修复术达成教科书结局与一年生存率改善相关
该研究基于VQI注册数据库,分析择期EVAR、TEVAR和cEVAR病例中达成教科书结局(TO)与1年死亡率的关系。结果显示TO达成率分别为77.6%、69.3%和61.1%,达成TO者1年生存率显著更高,且TO是1年死亡的最强保护因素。
要点
- EVAR、TEVAR和cEVAR达成TO者1年生存率均显著高于未达成者(P<0.001)。
- 调整协变量后,TO是1年死亡的最强保护因素(EVAR HR 0.36,TEVAR HR 0.27,cEVAR HR 0.24)。
- 年龄>75岁、术前肌酐>1.7 mg/dL、女性、充血性心力衰竭和功能依赖状态与TO失败相关。
核心结论
- EVAR、TEVAR和cEVAR未达成TO与1年死亡率相关,TO可作为综合质量指标指导质量改进。
研究设计与样本
- 回顾性队列研究,查询VQI注册数据库中选择性治疗动脉瘤疾病的EVAR(2003-2023)、TEVAR和cEVAR(2011-2023)病例。
主要发现
- TO达成率:EVAR 53,008例(77.6%),TEVAR 2,276例(69.3%),cEVAR 3,306例(61.1%)。
- 1年生存率(TO vs 非TO):EVAR 96.3±0.1% vs 87.0±0.6%;TEVAR 94.2±1.2% vs 78.3±2.7%;cEVAR 94.8±1.0% vs 82.0±2.0%(P<0.001)。
- Cox回归中TO对1年死亡的保护作用:EVAR HR 0.36(95%CI 0.33-0.39),TEVAR HR 0.27(95%CI 0.27-0.35),cEVAR HR 0.24(95%CI 0.20-0.30),均P<0.001。
- 多变量调整后TO失败的共同相关因素包括年龄>75岁、术前肌酐>1.7 mg/dL、女性、充血性心力衰竭和功能依赖状态(均P<0.05)。
关键数值与推荐
- TO定义为无主要术后并发症、无围术期再干预/死亡、无延长住院时间且出院回原住所。
临床怎么用
- TO可作为评估EVAR、TEVAR和cEVAR质量的综合指标,强调患者选择、围术期优化和护理流程的重要性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the association of achieving a textbook outcome (TO) in endovascular aortic repair (EVAR) on 1-year mortality and identify risk factors associated with failure to achieve at TO. BACKGROUND: TO has been described as a composite measure of the most desirable surgical outcome. The association of TOs with survival and risk factors associated with failing to achieve a TO have not been previously examined for EVAR, thoracic EVAR (TEVAR), or fenestrated/branched (complex) EVAR (cEVAR). METHODS: The vascular quality initiative registries for EVAR (2003-2023), TEVAR, and cEVAR (2011-2023) were queried for elective cases performed for aneurysmal disease. TO was defined as freedom from major postoperative complications, perioperative reintervention/mortality, prolonged length of stay, and discharge to previous residence. TO and non-TO patient demographics, postoperative outcomes, and 1-year survival were analyzed. Regression analysis was performed to define variables associated with failure to achieve a TO. RESULTS: TO was achieved in 53,008 (77.6%), 2276 (69.3%), and 3306 (61.1%) of EVAR, TEVAR, and cEVAR procedures, respectively. Kaplan Meier estimates of 1-year survival were significantly higher for all TO patients versus non-TO [EVAR: 96.3 ± 0.1% vs 87.0 ± 0.6%; TEVAR: 94.2 ± 1.2% vs 78.3 ± 2.7%; cEVAR: 94.8 ± 1.0% vs 82.0 ± 2.0% (P < 0.001)]. Achieving a TO was the most protective factor against 1-year mortality when adjusting for other covariates on Cox regression analysis [EVAR hazard ratio (HR): 0.36; 95% CI: 0.33-0.39, TEVAR HR: 0.27; 95% CI: 0.27-0.35. cEVAR HR: 0.24; 95% CI: 0.20-0.30, all P < 0.001]. Common factors associated with failure to achieve TO after multivariable adjustment included age >75 years, preoperative creatinine>1.7 mg/dL, female sex, congestive heart failure, and dependent functional status (all, P < 0.05). CONCLUSIONS: Failure to achieve TO in EVAR, TEVAR, and cEVAR is associated with 1-year mortality. This association demonstrates the importance of patient selection, perioperative optimization, and processes of care. As such, it represents a comprehensive composite metric incorporating the priorities of both patients and physicians and may be useful for guiding quality improvement efforts.
引用
- Sickels AD, Banks CA, Filiberto AC, et al. "Textbook Outcome" in Endovascular Aortic Repair is Associated With Improved One-year Survival. Ann Surg. 2024. PMID: 41952205. doi:10.1097/SLA.0000000000006590
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。